- Home
- BBAR vs PTGX Comparison
BBAR vs PTGX Comparison
Compare BBAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBAR | PTGX |
|---|---|---|
| Founded | 1886 | 2006 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 5.2B |
| IPO Year | 1997 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BBAR | PTGX |
|---|---|---|
| Price | $15.54 | $102.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 13 |
| Target Price | $17.00 | ★ $107.38 |
| AVG Volume (30 Days) | 737.5K | ★ 826.9K |
| Earning Date | 05-20-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.21 | $873.97 |
| Revenue Next Year | $13.00 | N/A |
| P/E Ratio | $26.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.76 | $39.60 |
| 52 Week High | $23.10 | $107.84 |
Technical Indicators
Market Signals| Indicator | BBAR | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 54.59 | 61.04 |
| Support Level | $15.23 | $76.63 |
| Resistance Level | $17.36 | N/A |
| Average True Range (ATR) | 0.86 | 4.71 |
| MACD | 0.35 | -0.08 |
| Stochastic Oscillator | 79.55 | 74.16 |
Price Performance
Historical ComparisonAbout BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.